A prospective randomized multicenter clinical evaluation of an anterior cervical fusion cage
A prospective randomized multicenter clinical evaluation of an anterior cervical fusion cage
复制标题
DOI:
10.1097/00007632-200010150-00017
复制
发表时间:
2000-10-15
期刊:
影响因子:
3
通讯作者:
Griffith, SL
中科院分区:
文献类型:
--
作者:
Hacker, RJ;Cauthen, JC;Griffith, SL
Study Design. A prospective, concurrently controlled randomized, multicenter trial of an anterior Bagby and Kuslich cervical fusion cage (BAK/C; Sulzer Spine-Tech, Minneapolis, MN) for treatment of degenerative disc disease of the cervical spine.Objectives. To report clinical results with maximum 24-month follow-up of fusions performed with the BAK/C fusion cage.Summary of Background Data. Threaded lumbar cages have been used during the past decade as a safe and effective surgical solution for chronic disabling low back pain. Threaded cages have now been developed for use in anterior cervical interbody fusions to obviate:the need for allografts or autogenous bone grafting procedures white providing initial stability during the fusion process.Methods. Patients with symptomatic cervical discogenic radiculopathy were treated with either anterior cervical discectomy with uninstrumented bone-only fusion (ACDF) or BAK/C fusion cage(s). Independent radiographic assessment of fusion was made and: patient-based outcome was assessed by visual analog pain scale and a Short Form (SF)-36 Health Status Questionnaire.Results. Data analysis included 344 patients at 1 year and 180 at 2 years. When the two cage groups (hydroxya, patite-coated or noncoated) were compared with the ACDF group, similar outcomes were noted for duration of surgery, hospital stay, improvements in neck pain and radicular pain in the affected limb, improvements:in the SF-86 Physical Component subscale and Mental Component subscale, and the patients' perception of overall surgical outcome: Symptom improvements were maintained at 2 years A greater percentage of patients with ACDF needed an iliac crest bone harvest than did BAK/C patients (67% vs. 3%). Successful fusion for one-level procedures at 12 months was 97.9% for the BAK/C groups and 89.7% Cor the ACDF group (P